Fangsheng Pharmaceutical announced that the company recently completed the registration of the “Pharmaceutical Production License” change and was issued a new certificate by the Hunan Drug Administration. The changes include: the production site on Lusong Road added the production scope of pills; the Wangcheng Economic Development Zone added the production scope of three new APIs; and acceptance of contracts from Xiangya Pharmaceutical and Ruixin Pharmaceutical to produce drugs, which are valid until November 27, 2030 and April 19, 2026, respectively. After the change, the license is valid until October 16, 2030. This change does not affect the current production structure and has no significant impact on the current period's results. Due to the characteristics of pharmaceutical products, there is a risk of uncertainty.

Fangsheng Pharmaceutical announced that the company recently completed the registration of the “Pharmaceutical Production License” change and was issued a new certificate by the Hunan Drug Administration. The changes include: the production site on Lusong Road added the production scope of pills; the Wangcheng Economic Development Zone added the production scope of three new APIs; and acceptance of contracts from Xiangya Pharmaceutical and Ruixin Pharmaceutical to produce drugs, which are valid until November 27, 2030 and April 19, 2026, respectively. After the change, the license is valid until October 16, 2030. This change does not affect the current production structure and has no significant impact on the current period's results. Due to the characteristics of pharmaceutical products, there is a risk of uncertainty.